Status History
2026-07-09
OPEN → HUMAN_REQUIRED
· This is not a grant programme — it is a VC fund with no public application portal. To pursue it Eniola must: (1) incorporate a company around one of her platforms (TOPOLOGIX, IMPRINT, or a CCT therapeutic entity); (2) prepare a standard VC pitch deck and one-pager; (3) secure a warm introduction to a16z Bio + Health (Vineeta Agarwala MD/PhD is the named GP) — the most viable route is through her academic collaborators Berridge (Michigan), Gershman (Harvard), Daw (Princeton), or Mattar (NYU), any of whom may have network ties to a16z or Lilly; alternatively, explore Lilly's Catalyze360 / Lilly Ventures as a direct entry point given Lilly is the fund's sole LP.